1269755-24-9 Usage
Uses
Used in Pharmaceutical Industry:
4-tert-butyl 2-methyl 2-methylmorpholine-2,4-dicarboxylate is used as a pharmaceutical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and improving the efficacy and safety of existing medications.
Used in Agrochemical Production:
4-tert-butyl 2-methyl 2-methylmorpholine-2,4-dicarboxylate is utilized in the production of agrochemicals, playing a crucial role in the development of effective and safe pesticides, herbicides, and other agricultural chemicals to protect crops and enhance agricultural productivity.
Used as a Solvent in Chemical Processes:
4-tert-butyl 2-methyl 2-methylmorpholine-2,4-dicarboxylate is employed as a solvent in various chemical processes, facilitating reactions and improving the efficiency of chemical synthesis.
Safety Precautions:
It is important to handle 4-tert-butyl 2-methyl 2-methylmorpholine-2,4-dicarboxylate with care, as it can be harmful if ingested, inhaled, or absorbed through the skin. Exposure should be avoided to ensure the safety of individuals working with 4-tert-butyl 2-methyl 2-methylmorpholine-2,4-dicarboxylate.
Check Digit Verification of cas no
The CAS Registry Mumber 1269755-24-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,9,7,5 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1269755-24:
(9*1)+(8*2)+(7*6)+(6*9)+(5*7)+(4*5)+(3*5)+(2*2)+(1*4)=199
199 % 10 = 9
So 1269755-24-9 is a valid CAS Registry Number.
1269755-24-9Relevant academic research and scientific papers
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
-
Page/Page column 176, (2014/02/15)
A series of imidazo[l,2-a]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
N-ACYL PYRIDINE BIARYL COMPOUNDS AND THEIR USES
-
Page/Page column 154, (2012/08/08)
The present invention provides a compound of general formula:wherein Z2-Z6 include one or two nitrogen atoms as described herein, including pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. These compounds inhibit the activity of CDK9 and are thus useful as pharmaceuticals. Also provided are methods of treating a disease or condition mediated by CDK9 using the compounds of Formula I and isomers thereof, and pharmaceutical compositions comprising such compounds.
HETEROARYL COMPOUNDS AS KINASE INHIBITORS
-
, (2011/04/14)
The present invention provides a compound of Formula (I): and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor
